MiNK Therapeutics, Inc.
INKT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001840229
No open-market purchases or sales by MiNK Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.39M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding MiNK Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 25 | 1 | 13 | −11 |
| Shares | 782.8K | 295 | 357.4K | −425.1K (−54.3%) |
| Value | $1.76M | $1.00K | $504.0K | −$1.26M (−71.4%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held MiNK Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Credit Suisse AG | 1 | $0 | 0.00% |
Sold out (12)
Institutions that held MiNK Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Sofinnova Investments, Inc. | 331,002 | $745.0K |
| Renaissance Technologies LLC | 25,760 | $58.0K |
| State Street Corp | 16,776 | $38.0K |
| Vanguard Group Inc | 10,348 | $23.0K |
| New York State Common Retirement Fund | 8,000 | $18.0K |
| American International Group, Inc. | 996 | $2.00K |
| California State Teachers Retirement System | 709 | $2.00K |
| Barclays PLC | 327 | $1.00K |
| Amalgamated Bank | 295 | $1.00K |
| Deutsche Bank AG | 12 | $0 |
| Royal Bank of Canada | 124 | $0 |
| Ameritas Investment Partners, Inc. | 150 | $0 |
Not filed for Q2 2022 yet (1)
Institutions that held MiNK Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 295 | $1.00K |